Figure 2.Evaluation the reliability of the risk signature in the training set (MMRF-COMMPASS). (A) summarizes the distribution of risk scores, the survival status of patients, and the expression of UPS genes in the training set. (B) A time-dependent ROC analysis for 1-, 3-, and 5-years OS prediction. (C) Survival analysis between low-risk and high-risk MM patients.
